Consensus in the Management of Multiple Myeloma in India at Myeloma State of the Art 2016 Conference

被引:13
|
作者
Yanamandra, Uday [1 ]
Khattry, Navin [2 ]
Kumar, Shaji [3 ]
Raje, Noopur [4 ]
Jain, Arihant [1 ]
Jagannath, Sundar [5 ]
Menon, Hari [6 ]
Kumar, Lalit [7 ]
Varma, Neelam [1 ]
Varma, Subhash [1 ]
Saikia, Tapan [8 ]
Malhotra, Pankaj [1 ]
机构
[1] PGIMER, Dept Internal Med, Chandigarh 160012, India
[2] Tata Mem Hosp, Dept Med Oncol, Bombay, Maharashtra, India
[3] Mayo Clin, Rochester, MN USA
[4] Massachusetts Gen Hosp, Ctr Canc, Boston, MA USA
[5] Tisch Canc Inst, New York, NY USA
[6] Cytecare Hosp, Bengaluru, India
[7] AIIMS, Dept Med Oncol, New Delhi, India
[8] Prince Aly Khan Hosp, Bombay, Maharashtra, India
关键词
Multiple myeloma; Consensus; Indian scenario; Plasma cell dyscrasia; STEM-CELL TRANSPLANTATION; DIAGNOSIS; THERAPY;
D O I
10.1007/s12288-016-0773-9
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The science of multiple myeloma (MM) and related plasma cell disorders is rapidly evolving with increased understanding of the disease biology and recent approval of the newer drugs widening the therapeutic armamentarium. Despite multiple international guidelines regarding the management of this disease, the practice of managing MM is not uniform amongst Indian physicians. There are challenges in management which are unique to the Indian patients. This review discusses these challenges and the consensus of the nation-wide experts in dealing with the same. We also briefly highlighted the perspective of international experts as discussed in the Myeloma State of the Art conference held in September 2016 at PGI, Chandigarh. An Indian Myeloma Academic Groupe (IMAGe) group was formed to strengthen the research, create awareness about myeloma and related disorders and form consensus guidelines/recommendations that can be adapted to the Indian Scenario.
引用
收藏
页码:15 / 21
页数:7
相关论文
共 50 条
  • [21] THE BELGIAN 2010 CONSENSUS RECOMMENDATIONS FOR THE TREATMENT OF MULTIPLE MYELOMA
    Schots, R.
    Delforge, M.
    Andre, M.
    Bries, G.
    Caers, J.
    Demuynck, H.
    De Prijck, B.
    De Samblanx, H.
    Kentos, A.
    Meuleman, N.
    Offner, F.
    Vekemans, M. C.
    Broek, I. Vande
    Van Droogenbroeck, J.
    Van de Velde, A.
    Wu, K. L.
    Doyen, C.
    ACTA CLINICA BELGICA, 2010, 65 (04) : 252 - 264
  • [22] Prognostic indicators of lenalidomide for multiple myeloma: consensus and controversy
    Kuroda, Junya
    Kobayashi, Tsutomu
    Taniwaki, Masafumi
    EXPERT REVIEW OF ANTICANCER THERAPY, 2015, 15 (07) : 787 - 804
  • [23] Recent trends in the management of newly diagnosed multiple myeloma
    Reece, Donna E.
    CURRENT OPINION IN HEMATOLOGY, 2009, 16 (04) : 306 - 312
  • [24] Progress in the Management of Smoldering Multiple Myeloma
    Schmidt, Timothy M.
    Callander, Natalie S.
    CURRENT HEMATOLOGIC MALIGNANCY REPORTS, 2021, 16 (02) : 172 - 182
  • [25] New Approaches to Management of Multiple Myeloma
    Genadieva-Stavric, Sonja
    Cavallo, Federica
    Palumbo, Antonio
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2014, 15 (02) : 157 - 170
  • [26] Radiological imaging in multiple myeloma: review of the state-of-the-art
    Francesca Di Giuliano
    Eliseo Picchi
    Massimo Muto
    Antonello Calcagni
    Valentina Ferrazzoli
    Valerio Da Ros
    Silvia Minosse
    Agostino Chiaravalloti
    Francesco Garaci
    Roberto Floris
    Mario Muto
    Neuroradiology, 2020, 62 : 905 - 923
  • [27] PHYSIOPATHOLOGY AND MANAGEMENT OF PAIN IN MULTIPLE MYELOMA
    Giovannini, M.
    Scaramucci, L.
    Tendas, A.
    Niscola, P.
    MINERVA MEDICA, 2010, 101 (06) : 427 - 438
  • [28] Risk and management of thrombosis in multiple myeloma
    Leebeek, Frank W. G.
    Kruip, Marieke J. H. A.
    Sonneveld, Pieter
    THROMBOSIS RESEARCH, 2012, 129 : S88 - S92
  • [30] Multiple myeloma: management of adverse events
    Gay, F.
    Palumbo, A.
    MEDICAL ONCOLOGY, 2010, 27 (03) : 646 - 653